Improving patient outcomes with MR-guided daily adapted SABR for prostate cancer

Author(s): Killian Nugent, Daniel Ford, Ami Sabharwal, Carla Perna, Prantik Das, Nicola Dallas, Philip Camilleri

Hospital: GenesisCare UK

Reference: RAD Magazine online


In the treatment of the most common cancer in men, the MRIdian MR-linac has enabled GenesisCare to take prostate cancer radiotherapy to the next level. Dr Killian Nugent shares the results of one of the largest patient reported outcomes studies demonstrating how the innovative technology of the MRIdian MR-linac is improving the accuracy and confidence with which treatment can be delivered to men with localised prostate cancer.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more